FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1238-1239 October 22, 1998 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Sasazuki, T. Related Article by Aversa, F. PubMed Citation

Bone marrow transplantation was first used successfully exactly 30 years ago, in children with congenital immune deficiencies.¹ The demonstration that bone marrow transplantation was also effective in treating aplastic anemia and malignant hematologic disorders followed a few years later. Its use for other indications, such as metastatic breast cancer and certain autoimmune diseases, is being explored. Annually, more than 30,000 patients undergo transplantation with bone marrow from a related or an unrelated donor (allogeneic transplantation) or with the patient's own, previously stored marrow (autologous transplantation). The results of marrow transplantations have steadily improved, but many patients receiving an allograft die . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bacigalupo, A. (2006). Unrelated transplants in aplastic anemia: are we making progress?. Blood 108: 1431-1431 [Full Text]  
• Eiermann, T. H., van Bekkum, D. W., Vriesendorp, H. M., Machida, U., Kami, M., Hirai, H., Bolan, C. D., Leitman, S. F., Sasazuki, T., Juji, T., Kodera, Y., Aversa, F., Martelli, M. F., Reisner, Y. (1999). Hematopoietic Stem-Cell Transplantation for Acute Leukemia. NEJM 340: 809-812 [Full Text]